|
Symbol
|
RMAJDV | RMB7FV | RMB8YV | ADXNSQ | LCTDDU | RMBQDV | RMA8PV | Z0CWSZ | Z0CYJZ | LDAWDU | RMAX6V |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible |
|
Sous-jacent
|
3M Co. / ABBVIE Inc. / Pfizer Inc. | ABBVIE Inc. / Johnson & Johnson / Pfizer Inc. | ABBVIE Inc. / Eli Lilly & Co. / Pfizer Inc. | ABBVIE Inc. / Eli Lilly & Co. / Pfizer Inc. | ABBVIE Inc. / Eli Lilly & Co. / Pfizer Inc. | ABBVIE Inc. / Eli Lilly & Co. / Johnson & Johnson / Pfizer Inc. | ABBVIE Inc. / Eli Lilly & Co. / Pfizer Inc. | ABBVIE Inc. / Bristol-Myers Squibb Co. / Johnson & Johnson | ABBVIE Inc. / Moderna Inc. / Pfizer Inc. | ABBVIE Inc. / Eli Lilly & Co. / Pfizer Inc. | ABBVIE Inc. / Eli Lilly & Co. / Johnson & Johnson |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
28.05.2027 | 20.12.2027 | 10.01.2028 | 13.01.2028 | 24.01.2028 | 25.01.2028 | 22.02.2028 | 17.08.2027 | 18.08.2027 | 11.09.2028 | 20.09.2027 |
| Demande | 101,00 | 100,60 | 100,70 | 101,23 | - | 100,80 | 103,60 | - | - | - | 101,10 |
| Offre | 102,00 | 101,60 | 101,50 | 102,09 | - | 101,80 | 104,40 | - | - | - | 102,10 |